A Case of Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy with Carboplatin plus Etoposide in a Hemodialysis Patient

Takeshi Terashima, Eri Iwami, Shotaro Chubachi, Shinnosuke Ikemura, Takahiro Nakajima, Tatsu Matsuzaki, Hiroshi Aoyagi

研究成果: Article査読

1 被引用数 (Scopus)

抄録

In recent years, many patients have had to undergo hemodialysis due to chronic renal failure. In addition, the number of hemodialysis patients in whom lung cancer is discovered is increasing. However, a standard chemoradiotherapy regimen for limited-disease small-cell lung cancer patients undergoing maintenance hemodialysis has not yet been established. We administered concurrent chemoradiotherapy using carboplatin 300 mg/m2 (day 1) plus etoposide 50 mg/m2 (day 1, 3). A partial response was achieved after 4 courses of chemotherapy and 68 Gy of radiotherapy. The major toxicities were hematological toxicities; they included grade 4 thrombocytopenia, grade 3 anemia, and neutropenia.

本文言語English
ページ(範囲)99-101
ページ数3
ジャーナルGan to kagaku ryoho. Cancer & chemotherapy
43
1
出版ステータスPublished - 2016 1 1
外部発表はい

ASJC Scopus subject areas

  • Medicine(all)

フィンガープリント 「A Case of Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy with Carboplatin plus Etoposide in a Hemodialysis Patient」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル